Key result
Mitochondrial cardiolipin plays a crucial role in maintaining cardiovascular health and driving disease pathogenesis.
Answers are grounded in this paper and cite their sources.
Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, is crucial for both mitochondrial function and cellular processes outside of the mitochondria. The importance of CL in cardiovascular health is underscored by the life-threatening genetic disorder Barth syndrome (BTHS), which manifests clinically as cardiomyopathy, skeletal myopathy, neutropenia, and growth retardation. BTHS is caused by mutations in the gene encoding tafazzin, the transacylase that carries out the second CL remodeling step. In addition to BTHS, CL is linked to other cardiovascular diseases (CVDs), including cardiomyopathy, atherosclerosis, myocardial ischemia-reperfusion injury, heart failure, and Tangier disease. The link between CL and CVD may possibly be explained by the physiological roles of CL in pathways that are cardioprotective, including mitochondrial bioenergetics, autophagy/mitophagy, and mitogen activated protein kinase (MAPK) pathways. In this review, we focus on the role of CL in the pathogenesis of CVD as well as the molecular mechanisms that may link CL functions to cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2015) conducted a review in Cardiovascular diseases. Cardiolipin was evaluated. Cardiolipin, the signature phospholipid of mitochondrial membranes, plays a crucial role in cardiovascular health and is linked to the pathogenesis of various cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: